It’s estimated that 90 percent of prostate cancer cases remain dormant and do not require clinical attention. However, when the cancer does show signs of growth, prostate cancer treatment generally is very effective. Nearly 100 percent of men survive the cancer five years after diagnosis, after 10 years the survival rate is 98... Read more
A new drug may offer another treatment option to men with advanced stages of prostate cancer.
While early-stage cancers can be monitored, but not necessarily acted on, advanced versions often require an invasive procedure, either through surgery or radiation. But the new drug, Zytiga, may provide an alternative to those... Read more
What is the PSA test?
Testing the amount of Prostate Specific Antigen (PSA) in the blood can help diagnose prostate cancer. PSA is a protein in the blood produced by prostate cells; a dramatic rise in the amount of PSA can indicate problems with the prostate gland, including prostate cancer, enlarged prostate, prostatitis or... Read more
In this era of minimally invasive medicine, High Intensity Focused Ultrasound (HIFU) deserves mention as a suitable option for ablative therapy for the treatment of organ-confined prostate cancer, and as a possible alternative to the more widely utilized treatments such as radiation therapy, robotic surgery or cryotherapy.
HIFU is a... Read more